postdocs Archives - Sanford Burnham Prebys
Institute News

Ceremony celebrates 2026 Fishman Fund awards for outstanding postdoctoral research 

AuthorCommunications
Date

September 18, 2026

Five young scientists at Sanford Burnham Prebys Medical Discovery Institute, whose research spans metabolic disease, cancer, aging and muscle-wasting disorders, were honored on September 17 at the 25th annual Fishman Fund awards ceremony. 

The Fishman Fund was created in 2001 by Sanford Burnham Prebys supporters Mary Bradley and Reena Horowitz to honor Dr. William and Mrs. Lillian Fishman, who founded the Institute in 1976. In 2010, Jeanne Jones became a co-founder designee. 

The awards are intended to support and promote early career scientists at Sanford Burnham Prebys. Four career development awards provide $10,000 stipends that can be used to attend workshops, network and travel to national and international conferences to learn about the latest developments in their research fields. In addition, the prizes include a two-year fellowship award, and an honor focused on rewarding research excellence. The fund is made possible through the generosity of many donors. 

The ceremony, which included poster presentations, was held at the Sanford Consortium for Regenerative Medicine. The 2026 recipients are:

Don Barach Memorial Fishman Fund Award

Lucía Alcober Boquet, PhD, works with Michael Karin, PhD, to study how specialized protein modifications help the body respond to metabolic stress, such as changes in nutrition, energy use, and liver function. 

By uncovering how liver metabolism normally works and goes awry in metabolic diseases, she hopes to reveal new opportunities for developing novel targeted treatments.

Alcober Boquet’s goal is to build a scientific career where she can help translate scientific discoveries into new therapies while fostering a supportive environment for future researchers.

Lucia Alcober Boquet, PhD

Jeanne Jones and Kathryn Fishback Fishman Fund Award

Dominic Denk, MD, MHBA, works with Michael Karin, PhD, to study to study how inflammation and metabolism shape the immune system’s ability to control cancers of the digestive system.

Denk has linked liver metabolism to the spread of cancer, opening the possibility of strengthening anti-cancer immunity using existing medications.

His long-term goal is to lead an independent, clinically focused research program that translates laboratory discoveries into new treatments.

Dominic Denk, MD

Reena and Sam Horowitz Founders Fishman Career Award

Amador Gallardo de los Reyes, PhD, works with Xiao Tian, PhD, to study how the brain ages. His research builds on the discovery that aging brain cells can regain more youthful characteristics.

By investigating how these rejuvenation strategies restore brain function, Gallardo hopes to uncover new approaches for preventing or treating dementia and other increasingly common neurodegenerative diseases.

His long-term goal is to establish an independent research program dedicated to understanding brain aging and developing new therapies.

Amador Gallardo de los Reyes, PhD

Fishman Fund Fellowship Award

Jimmy Massenet, PhD, works with Pier Lorenzo Puri, MD, to study changes in the way DNA is organized inside muscle cells that contribute to muscle-wasting diseases. He focuses on problematic proteins in diseased cells that no longer properly organize and regulate genetic information. 

Massenet has identified early disease-related changes that may provide opportunities for intervention before significant muscle loss occurs. 

He is now investigating new biomarkers and treatment strategies aimed at maintaining muscle mass and function to improve patients’ quality of life. 

Jimmy Massenet, PhD

Lenka Finci and Erna Viterbi Fishman Fund Award

Robert Wiesheu, PhD, works with Kelly Kersten, PhD, to study immune cells called myeloid cells that influence the growth and spread of melanoma. His research explores how these cells shape the tumor environment, influence the effectiveness of immunotherapy and contribute to metastasis.

Wiesheu plans to enter the biotechnology or pharmaceutical industry to help guide the development of new cancer therapies. His goal is to accelerate immunotherapy research so that more patients can be treated and live longer, healthier lives.

Robert Wiesheu, PhD

For more information on the Fishman Fund or to learn more about our philanthropy program, please contact giving@sbpdiscovery.org. 

Institute News

Q & A with Postdoctoral Researcher Bastien Cimarosti, from the Ranade Lab

AuthorCommunications
Date

September 14, 2026

Meet one of our early-career scientists at Sanford Burnham Prebys Medical Discovery Institute: Bastien Cimarosti, PhD, a postdoctoral researcher in the lab of Sanjeev Ranade, PhD. Cimarosti studies how the heart forms and what causes congenital heart defects.

When and how did you become interested in science?
For as long as I can remember, I’ve always been curious about the world around me. For example, when I was growing up, I loved to visit castles from the Middle Ages to understand more about our history or read books about physics and engineering.

During high school, I fell in love with biology thanks to a couple of teachers. Later I went to medical school, and it made me appreciate even more that there are so many things we don’t understand yet about human biology. That led me to a research career where I could explore my curiosity about the unknown.

What are the key areas of research you focus on?
I have a lot of different projects, but they all have in common that we are trying to understand what leads to babies being born with congenital heart defects. And how these conditions will affect patients throughout their lives.

Thanks to advances in medicine and surgical practice, most children born with congenital heart defects will reach adulthood. Even after surgery, however, the disease is still present and affects how patients develop and age over time.

We still have a lot to learn about what causes congenital heart defects. By better understanding the genetic or environmental factors at play, perhaps one day we will be able to prevent the disease from occurring in the first place.

What motivates you about your research?
On a day-to-day basis, my motivation is to do the basic science we need to understand how the heart forms and how perturbations during pregnancy can affect the heart.

Also, I use a lot of what are called omics techniques that can capture the complexity of living systems. I’m using different bioinformatics tools and machine learning tools to analyze the large datasets produced by these techniques. Because the datasets are so wide and capture a large portion of the underlying biology, I like that I am never stuck and can switch very quickly between ideas based on what I see in the data.

What do you like about working here?
The training environment for postdocs is just amazing. The core research facilities are tremendous as well. I work a lot with the genomics core and the experts there are terrific. You can just keep advancing science without thinking about technical constraints because everything you need is on campus and available to you.

What I love the most, though, is being with my lab. I love being able to work with my mentors, peers and colleagues, and being surrounded by smart and talented people.

Bastien Cimarosti photo collage in the lab

What are your career goals?
My goal is to stay in academia, become a principal investigator and open my own lab. I would like to continue working on cardiac developmental biology and how cardiac diseases develop.

What do you enjoy doing when you’re not in the lab?
I love nature and being outside. I love hiking in the mountains around San Diego, going to the beach and swimming. And I look forward to meeting up with friends whenever we can to explore national parks together.

Postdocs at Sanford Burnham Prebys are pushing the boundaries of science every day through curiosity, collaboration, and innovation. This series highlights their unique journeys, what inspires their work, and the impact they’re making across our labs.

Explore the Full Series

Institute News

Sanford Burnham Prebys Science Network hosts Community Outreach Symposium showcasing early-career research

AuthorCommunications
Date

June 19, 2026

Graduate students and postdoctoral researchers from across Sanford Burnham Prebys took center stage at the 2026 Community Outreach Symposium, sharing their research with colleagues and mentors from across the Institute, as well as members of the broader community. 

Organized by the Sanford Burnham Prebys Science Network (SBP-SN) and the Office of Learning and Development, the event aims to spark excitement about biomedical research and build trust with the public, while providing trainees with an opportunity to communicate their science to a diverse audience in short 3-minute talks.

The symposium included a Postdoc Pitch Competition, where postdoctoral researchers competed for the opportunity to represent Sanford Burnham Prebys in a mesa-wide competition this fall against peers from Scripps Research, Salk Institute for Biological Studies and the University of California San Diego.

The event also featured a Science Communication Competition, where seven graduate students presented their research and competed for audience votes. The friendly competition highlighted the importance of effective science communication and public engagement.

Postdoc Pitch speakers:

  • Jimmy Massenet, PhD, Puri lab — CTCF: The Pillars That Hold Our Genome
  • Julia Schoenfeld, PhD, Cosford lab — One STEP Forward in the Fight Against Alzheimer’s Disease
  • Ryan Loughran, PhD, Emerling lab — PIPKs: Sorting Out Your Cell’s Delivery System
  • Kokila Shankar, PhD, Sheffler lab — Don’t Stress: Targeting Stress Signaling to Treat Brain Disorders- (First place Judges’ Selection and People’s Choice Award)
  • Jessica Proulx, PhD, Adams lab — Game of Genes: A Song of Activation & Silencing – (Second place Judges’ Selection)

Drs. Kokila Shankar and Jessica Proulx will compete in the Torrey Pines Mesa-wide Postdoc Pitch Competition this fall.

Science Communication Competition presenters:

  • Anamika Yadav, Sinha lab — The Aging Rollercoaster Inside Us
  • Alisha Kirkland, Spruck lab — Cold Breast Tumors Go Viral – (First place People’s Choice)
  • Anna Chechenina, Sinha lab — Your Liver Has a Bad Neighborhood: Finding Where Aging Moves In
  • Sophie Hao, Dong lab — When Yellow Isn’t Mellow: The Race to Cure Biliary Atresia – (Second place People’s Choice)
  • Carolina Cano Macip, Tian lab — Unlocking Nature’s Secrets to Healthy Aging 
  • Erik Hultenius, Tian lab — Anti-Aging Interventions for the Treatment of Alzheimer’s Disease
  • Patrick Hagan, Cosford lab — ATG Attack: Developing New Drugs for Pancreatic Cancer

The symposium also featured a keynote presentation by Sanjeev Ranade, PhD, assistant professor in the Center for Cardiovascular and Muscular Diseases. Ranade shared highlights from his research on congenital heart disease and developmental biology, while also reflecting on the mentors, experiences and scientific communication opportunities that shaped his career.

Drawing on his own career journey, Ranade encouraged trainees to take chances and remain open to unexpected opportunities. He shared how a seemingly small decision to submit an abstract ultimately set in motion a series of events that led to new collaborations, funding opportunities and eventually a faculty position at Sanford Burnham Prebys. Success, he noted, often comes not from following a carefully mapped path, but from being willing to step forward when opportunities arise.

The event concluded with award announcements, followed by a reception hosted by SBP-SN that provided additional opportunities for networking and scientific discussion.

By bringing together members of the Sanford Burnham Prebys community and guests from the broader community, the symposium fostered collaboration, scientific exchange and public engagement while helping early-career researchers strengthen the communication skills needed to share their discoveries beyond the laboratory.

Special thanks to our judges for their time and participation:

  • Nan Eastman
    Fishman Community Advisory Board Member
  • Mitchell Furumoto
    Associate Director, International Services, Sanford Burnham Prebys
  • Liz Hincks
    Director, Communications, Sanford Burnham Prebys
  • Eric Meyer
    Assistant Director, Fleet Science Center
  • Jill Roughan, PhD
    Founder and President of Sciencia Consulting
Institute News

Q & A with Postdoctoral Researcher Kokila Shankar, from the Sheffler Lab

AuthorCommunications
Date

June 15, 2026

Meet one of our early-career scientists at Sanford Burnham Prebys Medical Discovery Institute: Kokila Shankar, PhD, a postdoctoral researcher in the lab of Douglas Sheffler, PhD. Shankar studies the brain stress signaling system to develop potential treatments for drug addiction.

When and how did you become interested in science?
My dad works in science, so I grew up seeing a little bit of that world. Within science, he works on the industry side which provided me with a perspective on how drug discovery works.

While I always liked science growing up, what really hooked me is when I learned about the field of neuroscience. You have to incorporate a lot of different types of knowledge to really understand neuroscience and neurobiology. And it’s one of the fields where I think that no matter how much we study it, there’s always going to be room to learn more and more.

What are the key areas of research you focus on?
I am really excited about the fact that I get to work in small molecule drug discovery for neurological and psychiatric disease. Currently, my focus is on treating drug addiction.

We use a drug discovery workflow to be able to take biological targets we’ve identified and develop small molecule chemicals that modify these targets. Essentially, we’re working on ways to either increase or decrease the activity of these targets as a strategy to potentially mitigate drug addiction symptoms.

More specifically, my main project is targeting the brain stress signaling system. By developing a small molecule that modulates a stress signaling receptor and some of its associated proteins, our goal is to change stress signaling in the brain. This is important because stress signaling is very involved in addiction. It can play a large role in people becoming addicted to substances and making their addiction worse and harder to quit.

What motivates you about your research?
I think in the field of drug discovery, people tend to portray making new medicines as a linear path. We have a small molecule identified through a screen that we know has some effects on a biological target. Then we just have to make it better, put it in cells, then in animals and finally we get it approved to put into people.

The reality is that there are so many things that can affect every single stage of that workflow. And there’s a lot of troubleshooting and interdisciplinary collaboration involved in keeping things on track. So even when things aren’t going smoothly, I remember that what I signed up to do as a scientist is solve problems. Each time we solve one, we also learn something new and that keeps me very motivated.

What do you like about working here?
Sanford Burnham Prebys feels like a very focused place to do research. Everyone’s goal is to work together to drive research forward. And you really feel that through the resources that are available, whether that’s the core facilities or the number of people that are available to collaborate or share reagents.

On top of that, the community here is very welcoming. Everyone is collaborative and wants to see each other succeed. And that’s rare to find in an academic research environment.

Kokila Shankar photo collage

What are your career goals?
My goal is to transition to a role in biotech or the pharmaceutical industry. And it would be even better if I was able to work in neuroscience therapeutics development.

Beyond that, I think a special aspect of being in science, earning a PhD and completing postdoctoral training is that it all prepares you for so many different types of careers. That could mean staying at the bench in R&D or moving into areas such as business, communications and marketing or science policy.

I feel like I’m very fortunate that there’s a lot of opportunities, and I don’t want to close the door on any of them.

What do you enjoy doing when you’re not in the lab?
I am an active volunteer with the Fleet Science Center, so I love doing their K-12 and their adult outreach programs to get more people excited about science.

Also, I used to be a competitive ballroom dancer. Right now, I’m enjoying the opportunity to work with students at the University of California San Diego to help them improve. And hopefully one day I’ll step back into competition.

Postdocs at Sanford Burnham Prebys are pushing the boundaries of science every day through curiosity, collaboration, and innovation. This series highlights their unique journeys, what inspires their work, and the impact they’re making across our labs.

Explore the Full Series

Institute News

Q & A with Postdoctoral Researcher Alejandro Lillo, PhD, from the Pasquale Lab

AuthorCommunications
Date

May 12, 2026

Meet one of our early-career scientists at Sanford Burnham Prebys Medical Discovery Institute: Alejandro Lillo, PhD, a postdoctoral researcher in the lab of Elena Pasquale, PhD. Lillo studies a family of protein receptors to uncover a new treatment approach for cancer patients.

When and how did you become interested in science?
When I was 15 years old, my parents told me that my mom was suffering from multiple sclerosis, a disease with no cure. At that time, I was a very good student interested in math, physics and biology.

I decided to focus all my efforts to become a scientist and be able to help people in the same situation. Even though I was frustrated, I tried to concentrate on positive things I could do to help people and contribute to new solutions as a researcher.

What are the key areas of research you focus on?
I am studying a small family of receptor tyrosine kinases called erythropoietin-producing hepatocellular receptors or EPH receptors. These receptors are highly implicated in different physiological and pathologic processes, including cancer.

Other experts have investigated these receptors as individual units, but we now know that these receptors can interact with each other to form groupings known as heterocomplexes. I am studying these heterocomplexes as part of a new potential therapeutic strategy for treating cancer.

What motivates you about your research?
Sometimes doing science can be frustrating. But I really love what I’m doing. Even when my hypotheses are wrong, I always try to think about why I got certain results and what I can learn from them.

I also reflect on why I chose this career, and it helps me to remember that I can benefit others by contributing to finding treatments for diseases with no cure.

What do you like about working here?
Most important to me is the family-like environment that we have here. Everybody is so collaborative and so helpful. Every time that I need something that we don’t have at the lab, I send an email and in five minutes I have a solution. We are collaborating with a lot of groups. And it goes both ways, so whenever other labs need something from us, we do our best to help out.

Also, something that is especially important for us postdocs, we have many different workshops, seminars and other resources to help us grow in our careers. And it is important for me to mention all the core facilities we have as they have been so supportive.

Thanks to them, I’ve developed skills in confocal microscopy, flow cytometry and mass spectrometry, adding to what I am learning inside the lab from my mentor.

Alejandro Lillo, PhD, photo collage

What are your career goals?
I want to be a principal investigator in academia. I am building my skills in proposal writing, leadership, public speaking and other areas needed to successfully build and run an independent research lab.

What do you enjoy doing when you’re not in the lab?
I love going to the beach and going hiking. And I enjoy going to the gym. It helps me to deal with stress and maintain my mental health.

Also, I am a food lover. Experiencing different kinds of cuisine makes me happy.

Postdocs at Sanford Burnham Prebys are pushing the boundaries of science every day through curiosity, collaboration, and innovation. This series highlights their unique journeys, what inspires their work, and the impact they’re making across our labs.

Explore the Full Series

Institute News

Q & A with Postdoctoral Researcher Nilofer Sayed, PhD, from the Dhar Lab

AuthorCommunications
Date

April 10, 2026

Meet one of our early-career scientists at Sanford Burnham Prebys Medical Discovery Institute: Nilofer Sayed, PhD, a postdoctoral researcher in the lab of Debanjan Dhar, PhD. Sayed studies the progression of fatty liver disease to cirrhosis and hepatocellular carcinoma to identify new potential treatments that could reverse or halt disease advancement.

When and how did you become interested in science?
Empathy for the sick led me to pursue a career as a physician in India. However, during my medical practice, I came to a point of understanding that I cannot help patients when existing treatment options are insufficient.

That insight led me to shift my gears and move towards a career in research to help find new therapies.

What are the key areas of research you focus on?
I work in a liver condition called metabolic dysfunction-associated steatohepatitis, or MASH, which involves the liver getting fatty and inflamed. The problem with this condition is that if it’s not treated on time, then it can progress to a much more severe form. 

At this stage, healthy liver tissue is replaced by scar tissue. This impairs the liver and can progress further into cancer.

I’m studying ways to stop this progression into more severe forms of liver disease. My major focus is on a particular immune cell population in the liver called macrophages. By manipulating this cell population, I’m trying to alter the immune landscape of this disease and inhibit its progression.

This is becoming increasingly important as the incidence of MASH continues to rise. We need to be able to prevent patients from developing cirrhosis, liver failure or hepatocellular carcinoma. 

How do you think about translating your findings to advance human health?
I believe that what I am researching has great potential to one day reach and help patients in the clinic. Once we can clarify the targets and the mechanisms, we will be able to test peptides or small molecules that modify the targets in order to inhibit the progression of the disease.

We’re fortunate to have drug screening capability here at the institute. This makes us more confident in our ability to move things forward when we identify promising druggable targets.

Nilofer Sayed, PhD, photo collage

What motivates you about your research?
The underlying motivation is to improve the lives of people that are sick. Because that is a long-term goal, though, I think it is important to have other sources of motivation that are more immediate.

Every day I wake up, I love heading to the lab to explore my ideas. As I plan and design my experiments, I’m excited to see what answers I get from them. Another fun part of being in the lab for me is troubleshooting. I enjoy figuring out what might be going wrong in experiments, not only for myself, but also for my fellow lab members or colleagues who are feeling stuck. I love the feeling of fixing something that isn’t working and getting the research back on track.

I also get motivated by attending as many of the scientific talks and seminars as I can. The speakers’ creativity and their meticulous experiments inspire me and provide insight into many areas of biomedical research.

What do you like about working here?
The work environment here gives researchers what they need to thrive. Collaboration is encouraged and the support that I get for my experiments from core facilities is wonderful.

I think Sanford Burnham Prebys has talented principal investigators that excel at generating ideas and guiding emerging scientists in the right direction. Also, this is a very translational research institute, which excites me because I know that what I achieve during my postdoctoral research has the potential of going forward and reaching patients.

This pushes me to work hard and accomplish something that can have an impact beyond scholarly publications by benefiting people.

What are your career goals?
I would like to stay in academic science and eventually run my own research lab that would focus on developing targeted immunotherapies for hepatocellular carcinoma.

What do you enjoy doing when you’re not in the lab?
I love going to church and visiting people who are sick in their hospital rooms or in their homes to try and bring some cheer and comfort.

I also enjoy cooking and going on long walks to admire nature.

Postdocs at Sanford Burnham Prebys are pushing the boundaries of science every day through curiosity, collaboration, and innovation. This series highlights their unique journeys, what inspires their work, and the impact they’re making across our labs.

Explore the Full Series

Institute News

La Jolla research meeting convenes scientists studying aging

AuthorCommunications
Date

March 25, 2026

Scientists gathered at the 9th annual La Jolla Aging Meeting on Thursday, March 19, 2026, in the Salk Institute’s Conrad T. Prebys Auditorium

The event brought together 286 attendees and featured short talks from San Diego-based postdoctoral researchers and students studying the biology of aging.

Anamika Yadav, a research assistant in the lab of Sanju Sinha, PhD, at Sanford Burnham Prebys Medical Discovery Institute, discussed her work studying aging by detecting structural alterations in cells and tissues over time captured in images taken of routine medical biopsies. She used data from the Genotype-Tissue Expression Project, a major National Institutes of Health Common Fund initiative that gathered samples from 970 non-diseased individuals aged 20 to 70. Yadav trained a computational model on more than 25,000 histopathology slides from 40 tissue types to define aging patterns in different tissues. By this approach, Yadav defined distinct patterns of aging in different tissues which ultimately can help to predict specific diseases of aging.

Beatrice Silvestri, PhD, a postdoctoral associate in the lab of Yu Xin (Will) Wang, PhD, at Sanford Burnham Prebys, shared findings from her work on an enzyme called 15-hydroxyprostaglandin dehydrogenase (15-PGDH). Researchers have defined 15-PGDH as a gerontological enzyme or “gerozyme” due its connection with aging in multiple tissues. Silvestri presented results from studying the effects of blocking 15-PGDH to ameliorate the degeneration of the connection between motor neurons and skeletal muscle fibers. Inhibition of this gerozyme might have potential for healthy aging and prevention of many diseases of aging.

In addition to these podium presentations, four Sanford Burnham Prebys scientists shared their research results during the meeting’s poster sessions:

The 2026 La Jolla Aging Meeting concluded with a keynote address by Ana Maria Cuervo, MD, PhD, Distinguished Professor and Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Albert Einstein College of Medicine.

Peter Adams, PhD, director of the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys, co-organized the La Jolla Aging Meeting with Alessandra Sacco, PhD, dean of the Sanford Burnham Prebys Graduate School of Biomedical Sciences and a professor in the Center for Cardiovascular and Muscular Diseases, and Salk Institute faculty members Jan Karlseder, PhD, and Gerald Shadel, PhD.

Institute News

Shanshan Yin named 2025 recipient of Eric Dudl Endowed Scholarship

AuthorGreg Calhoun
Date

March 24, 2026

Yin, a postdoctoral associate at Sanford Burnham Prebys, received the honor in recognition of her achievements in research on cancer and aging

Shanshan Yin, PhD, was named the 2025 recipient of The Eric Dudl Endowed Scholarship at Sanford Burnham Prebys Medical Discovery Institute. 

The scholarship fund was established at the institute to remember Eric Dudl, a postdoctoral researcher whose life was tragically cut short by cancer at the age of 33. Since 2007, 18 postdoctoral scientists have received support for their research from the endowed scholarship fund. 

Yin is a postdoctoral associate in the lab of Peter Adams, PhD, director of the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys. She wants to understand why the incidence of cancer increases with age. Yin studies changes in gene expression and immune system activity in breast cancer tumors as mice age.  

Her research has shown that part of the reason that breast cancer is more common with age is because of an impaired immune system. Immune dysfunction due to aging allows the tumors to grow more frequently and more rapidly. Additional research on these findings may guide future preventive treatments.

Yin has garnered recognition throughout her scientific career, including the 2022 Lenka Finci and Erna Viterbi Fishman Fund Award from Sanford Burnham Prebys.  

“I’m grateful for the Dudl family’s kindness and generosity,” said Yin. “I am moved by Eric’s determination, bravery and love for life and for science, and I would like to carry his example with me going forward and do my best to honor his legacy.” 

“It’s been a real pleasure working with Shanshan over the years,” said Adams. “She truly does embody Eric Dudl’s commitment to and passion for science which is expressed so well by this inspirational award.”  

Eric Dudl

The Eric Dudl Endowed Scholarship at Sanford Burnham Prebys was established at the institute to remember Eric, a postdoctoral researcher whose life was tragicallycut shortby cancerat the age of 33.

For more information on setting up a scholarship or to learn more about our philanthropy program, please contact giving@sbpdiscovery.org. 

Institute News

Jimmy Massenet selected for Science in Motion Travel Award

AuthorCommunications
Date

March 3, 2026

The Sanford Burnham Prebys Center for Cardiovascular and Muscular Diseases recently announced that Jimmy Massenet, PhD, is a recipient of a 2026 Science in Motion Travel Award. 

Massenet, a postdoctoral associate in the lab of Pier Lorenzo Puri, MD, was selected to attend the 2026 Muscle Stem Cells and Regeneration Meeting held from July 19-24, 2026, in Victoria, the capital of the Canadian province of British Columbia. 

The goal of the Science in Motion Travel Award is to support conference participation for emerging researchers in labs with a primary affiliation in the Center for Cardiovascular and Muscular Diseases. 

Applications will open again on July 15, 2026.

Institute News

Q & A with Postdoctoral Researcher Dominic Denk, MD, MHBA, from the Karin Lab

AuthorCommunications
Date

March 2, 2026

Meet one of our early-career scientists at Sanford Burnham Prebys Medical Discovery Institute: Dominic Denk, MD, MHBA, a postdoctoral researcher in the lab of Michael Karin, PhD. Denk studies cancer and gastrointestinal malignancies with a focus on how the immune system reacts to tumors and how to improve immunotherapies.

When and how did you become interested in science?
It was quite by chance. I’m a physician by trade in Germany, and the first way I got into science was through medical school. You learn about topics such as biochemistry and physiology, and it leads you to wonder about what processes behind the scenes. These subjects sparked my interest, and I started reading articles and books on my own time in the library.

And then the second reason is that, in Germany, you are expected to do research for a few months to earn your academic credentials. It naturally pushed me into the research world and made me realize how much I like running experiments and analyzing data.

What did you imagine you would be doing professionally, and how did it evolve?
I had many ideas. For quite some time while I was younger, I wanted to be a sports journalist.

My mom is a physician’s assistant and was always watching medical shows on TV in the background when I was growing up. I was never pushed into healthcare, but it was always present. Once I got to high school and found I enjoyed health and science courses, I started to think about going to medical school.

And once I started, I never looked back because I love being a physician.

What are the key areas of research you focus on?
I work on cancer and gastrointestinal malignancies. I want to better understand how the immune system reacts to tumors and how to improve immunotherapies. Immunotherapies have become the standard of care for many cancers, but not necessarily those in the gastrointestinal tract.

Back in Germany. I worked on colorectal cancer and now I’m looking at pancreatic cancer. We want to know what makes pancreatic cancer metastasize to the liver because it is a tumor that spreads to the liver quite often.

Once it does, the prognosis is much, much worse. If we can learn what attracts pancreatic cancer cells to the liver and why the disease becomes more malignant there, it may lead to methods for preventing the cancer from spreading and better treating it if it has spread.

What motivates you about your research?
Ultimately, it is about improving patient care. I have had the privilege of working in a large academic center that takes care of a lot of GI cancer patients. I have seen many patients with hepatocellular carcinoma undergo liver transplantation and experienced a cure in the end.

Dominic Denk photo collage working in the lab

But for most patients, it’s not the case. I have seen patients who came to the hospital concerned about weight loss only to be diagnosed with advanced stage cancers. I’ve cared for people over months and seen them deteriorate. It’s terrible and makes me wonder if there is something more we can do.

We’ve had great advances for many malignancies, but not for every patient. And research is how we will get to a better place for more patients and their families.

What do you like about working here?
There is a great sense of community, I think, and tons of scientific seminars across different fields. Everybody is very friendly and collaborative.

One thing that stands out is that there is very little red tape when it comes to solving problems. Recently, we had an incubator breaking down. We wrote one email and it was fixed within an hour or so. And that could have been catastrophicand led to months of delays for many projects in our lab.

What are your career goals?
Ideally, I will continue being a physician-scientist using the expertise I’m building upon here in the Karin lab. I would like to start a small lab so that I could continue to care for patients while working with trainees and mentees to maintainresearch momentum.

As a practicing physician and a researcher, I would love to help bridge the gap between the basic science laboratory bench and the clinic. Too many promising projects never make it past the lab bench to actually be tested in the real world. We’ll never know if some of these ideas could help people if we don’t advance them from petri dishes and animal models to see how they perform in clinical trials.

What do you enjoy doing when you’re not in the lab?
I’m doing tons of hiking and enjoy exploring the area. I try to spend as much time as possible on the beach, so my big non-science goal for 2026 is to learn how to surf.

Postdocs at Sanford Burnham Prebys are pushing the boundaries of science every day through curiosity, collaboration, and innovation. This series highlights their unique journeys, what inspires their work, and the impact they’re making across our labs.

Explore the Full Series